XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF DISAGGREGATED REVENUE

For the three months ended March 31, 2022 and 2021, the Company had the following disaggregated revenue:

 

   Three Months Ended March 31, 
   2022   %   2021   % 
Telehealth revenue  $22,598,061    78%  $13,283,315    73%
WorkSimpli revenue   6,444,776    22%   4,914,797    27%
Total net revenue  $29,042,837    100%  $18,198,112    100%
SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY

The Company records deferred revenues when cash payments are received or due in advance of its performance. The Company’s deferred revenues relate to payments received for the in-process monthly or yearly contracts with customers and a portion attributable to the yet to be recognized initial 14-day trial period collections.

 

   2022   2021 
   Three Months Ended March 31, 
   2022   2021 
Beginning of period  $1,499,880   $916,880 
Additions   6,367,970    5,024,866 
Revenue recognized   (6,079,295)   (4,602,437)
End of period  $1,788,555   $1,339,309 
SUMMARY OF INVENTORY

As of March 31, 2022 and December 31, 2021, the Company’s inventory consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
         
Finished Goods - Products  $1,215,022    1,592,654 
Raw materials and packaging components   82,493    81,427 
Inventory reserve   (57,481)   (57,481)
Total Inventory - net  $1,240,034   $1,616,600 
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

The following table summarizes the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares:

 

   Three Months Ended March 31, 
   2022   2021 
         
Series B Preferred Stock   1,299,389    1,162,466 
Restricted Stock Units (RSUs)   1,412,500    47,500 
Stock options   4,376,931    4,395,000 
Warrants   3,859,638    3,550,471 
Potentially dilutive securities   10,948,458    9,155,437